Impact ofIFNL4rs12979860 and rs8099917 polymorphisms on response to Peg-Interferon-α and Ribavirin in patients with congenital bleeding disorder and chronic hepatitis C-Reference-Cited by-同舟云学术

Impact ofIFNL4rs12979860 and rs8099917 polymorphisms on response to Peg-Interferon-α and Ribavirin in patients with congenital bleeding disorder and chronic hepatitis C

Published:2016-10-13 Issue:4 Volume:31 Page:e22063
ISSN:0887-8013
Container-title:Journal of Clinical Laboratory Analysis
language:en
Short-container-title:J Clin Lab Anal

Author:

Keshvari Maryam¹,Alavian Seyed Moayed²³,Behnava Bita²³,Pouryasin Ali⁴⁵,Craig Johanna C.⁶,Sharafi Heidar²³⁴

Affiliation:

1. Blood Transfusion Research Center; High Institute for Research and Education in Transfusion Medicine; Tehran Iran

2. Baqiyatallah Research Center for Gastroenterology and Liver Diseases; Baqiyatallah University of Medical Sciences; Tehran Iran

3. Middle East Liver Diseases (MELD) Center; Tehran Iran

4. Armin Pathobiology Laboratory; Tehran Iran

5. Department of Biology; Arsanjan Branch; Islamic Azad University; Arsanjan Iran

6. GATACA; LLC; Corporate Research Center; Virginia Polytechnic Institute and State University; Blacksburg VA USA

Funder

Armin Pathobiology Laboratory and Baqiyatallah Research Center for Gastroenterology and Liver Diseases

Publisher

Wiley

Subject

Microbiology (medical),Biochemistry (medical),Medical Laboratory Technology,Clinical Biochemistry,Public Health, Environmental and Occupational Health,Hematology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jcla.22063/fullpdf

Reference41 articles.

1. Organization WH Hepatitis C 2015

2. Prevalence of hepatitis C virus antibody in a cohort of hemophilia patients [see comments];Brettler;Blood,1990

3. Lack of knowledge about hepatitis C infection rates among patients with inherited coagulation disorders in countries under the eastern mediterranean region office of WHO (EMRO): a meta-analysis;Alavian;Hepat Mon,2012

4. Next steps for eradication of hepatitis C in the era of direct acting antivirals;Hesamizadeh;Hepat Mon,2016

5. Antiviral therapy reduces risk of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis;Singal;Clin Gastroenterol Hepatol,2010

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trends in the Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infections in Iranian Patients with Hereditary Bleeding Disorders;Pathogens;2023-04-04

2. Treatment of hepatitis C virus infection with direct-acting antiviral agent-based regimens in Iranian patients with hereditary bleeding disorders;Virology Journal;2021-10-07

3. Real-life efficacy of generic sofosbuvir/ledipasvir for treatment of Iranian patients with chronic hepatitis C: A cohort study;CASP J INTERN MED;2020

4. Pooled Prevalence of NS5A Resistance-Associated Substitutions in Chronic HCV Genotype 3 Infection: A Study Based on Deposited Sequences in GenBank;Microbial Drug Resistance;2019-09-01

5. The efficacy of adding vitamin B12 to pegylated interferon and ribavirin treatment in Hepatitis C virus patients regarding the host and viral prognostic factors;Biomedical Research and Therapy;2019-02-28